SCHEMBL28808909

SCHEMBL28808909

Nc1ccc(Oc2ccc(C(=O)C(COCc3ccccc3)NC(=O)c3ccc4[nH]ccc4c3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
PADI4 Q9UM07 1/20 0.44
PADI2 Q9Y2J8 1/20 0.44
JAK2 O60674 1/20 0.43
S1PR1 P21453 7/20 0.41
LNPEP Q9UIQ6 1/20 0.39
CTNNB1 P35222 1/20 0.39
WNT3A P56704 1/20 0.39
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
ENPP2 Q13822 1/20 0.38
MAPK14 Q16539 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
SMYD3 Q9H7B4 1/20 0.37
NFATC1 O95644 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923593 0.93 JAK2 (0.43) TAS1R3TAS1R1PADI4PADI2JAK2
SCHEMBL28808910 0.91 TAS1R3 (0.42) TAS1R3TAS1R1PADI4PADI2JAK2
SCHEMBL28808912 0.88 TAS1R3 (0.42) TAS1R3TAS1R1PADI4PADI2JAK2
SCHEMBL1371827 0.84 S1PR1 (0.59) TAS1R3TAS1R1PADI4PADI2JAK2
SCHEMBL27923595 0.84 TAS1R3 (0.41) TAS1R3TAS1R1PADI4PADI2JAK2
SCHEMBL27923609 0.83 JAK2 (0.44) JAK2S1PR1LNPEPMAPK14HDAC3
SCHEMBL27923596 0.81 TAS1R3 (0.39) TAS1R3TAS1R1PADI4PADI2JAK2
SCHEMBL1375523 0.77 S1PR1 (0.60) TAS1R3TAS1R1JAK2S1PR1
SCHEMBL27942617 0.75 UGCG (0.43) JAK2S1PR1
SCHEMBL27923611 0.74 JAK2 (0.44) JAK2S1PR1LNPEPMAPK14HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102245174-B Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents EXELIXIS INC 2013-11-06 CN disclosed